Ann: MPL Manufacturing and Human Trials Update, page-51

What failure are you talking of Bucky? The successful lengthening of average dog life with barely any side effects by fighting an aggressive cancer with a simple pill and the almost certain prospect this will be repeated in humans suffering late stage terminal cancer next year? That's failure? This is what mTOR research for the last thirty years has promised but has had difficulties delivering and you call that failure????? Do you even begin to understand the implications both for treatment and the company's negotiating strength?

Mate, you only see problems and failure. There have been other whingers before you but they've come and gone but you drone on.........